Micronutrient deficiency and immunity

Nutrition-Infection Interactions and Impacts on Human Health

Volumn , Issue , 2014, Pages 39-58

  Cusick, Sarah E ^a   John, Chandy C ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85006352503     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b17311     Document Type: Chapter

References (128)

1. Ramakrishnan, U., Prevalence of micronutrient malnutrition worldwide. Nutr Rev, 2002. 60(5 Pt 2): S46-52.
2. Stoltzfus, R., Defining iron-deficiency anemia in public health terms: A time for reflection. J Nutr, 2001. 131(2S-2): 565S-7S.
3. Muthayya, S. et al., The global hidden hunger indices and maps: An advocacy tool for action. PLoS One, 2013. 8(6): e67860.
4. Black, R.E. et al., Maternal and child undernutrition: Global and regional exposures and health consequences. Lancet, 2008. 371(9608): 243-60.
5. Habicht, J.P., Malnutrition kills directly, not indirectly. Lancet, 2008. 371(9626): 1749-50; author reply 1750.
6. Beard, J.L., Iron biology in immune function, muscle metabolism and neuronal functioning. J Nutr, 2001. 131(2S-2): 568S-79S; discussion 580S.
7. Dallman, P.R., Iron deficiency and the immune response. Am J Clin Nutr, 1987. 46(2): 329-34.
8. Drakesmith, H. and A.M. Prentice, Hepcidin and the iron-infection axis. Science, 2012. 338(6108): 768-72.
9. Oppenheimer, S.J., Iron and its relation to immunity and infectious disease. J Nutr, 2001. 131(2S-2): 616S-33S; discussion 633S-5S.
10. Hershko, C., Iron, infection and immune function. Proc Nutr Soc, 1993. 52(1): 165-74.
11. Kuvibidila, S. et al., Influence of iron-deficiency anemia on selected thymus functions in mice: Thymulin biological activity, T-cell subsets, and thymocyte proliferation. Am J Clin Nutr, 1990. 51(2): 228-32.
12. Chandra, R.K. and A.K. Saraya, Impaired immunocompetence associated with iron deficiency. J Pediatr, 1975. 86(6): 899-902.
13. Joynson, D.H. et al., Defect of cell-mediated immunity in patients with iron-deficiency anaemia. Lancet, 1972. 2(7786): 1058-9.
14. Ekiz, C. et al., The effect of iron deficiency anemia on the function of the immune system. Hematol J, 2005. 5(7): 579-83.
15. Macdougall, L.G. et al., The immune response in iron-deficient children: Impaired cellular defense mechanisms with altered humoral components. J Pediatr, 1975. 86(6): 833-43.
16. Feng, X.B., X.Q. Yang, and J. Shen, Influence of iron deficiency on serum IgG subclass and pneumococcal polysaccharides specific IgG subclass antibodies. Chin Med J (Engl), 1994. 107(11): 813-6.
17. Thibault, H. et al., The immune response in iron-deficient young children: Effect of iron supplementation on cell-mediated immunity. Eur J Pediatr, 1993. 152(2): 120-4.
18. Sipahi, T. et al., Serum interleukin-2 and interleukin-6 levels in iron deficiency anemia. Pediatr Hematol Oncol, 1998. 15(1): 69-73.
19. Kuvibidila, S.R. et al., Iron deficiency reduces serum and in vitro secretion of interleukin-4 in mice independent of altered spleen cell proliferation. Nutr Res, 2012. 32(2): 107-15.
20. Dhur, A., P. Galan, and S. Hercberg, Iron status, immune capacity and resistance to infections. Comp Biochem Physiol A Comp Physiol, 1989. 94(1): 11-9.
21. Hallquist, N.A. et al., Maternal-iron-deficiency effects on peritoneal macrophage and peritoneal natural-killer-cell cytotoxicity in rat pups. Am J Clin Nutr, 1992. 55(3): 741-6.
22. Spear, A.T. and A.R. Sherman, Iron deficiency alters DMBA-induced tumor burden and natural killer cell cytotoxicity in rats. J Nutr, 1992. 122(1): 46-55.
23. Weinberg, E.D., Modulation of intramacrophage iron metabolism during microbial cell invasion. Microbes Infect, 2000. 2(1): 85-9.
24. Collins, H.L., Withholding iron as a cellular defence mechanism-Friend or foe? Eur J Immunol, 2008. 38(7): 1803-6.
25. Recalcati, S., M. Locati, and G. Cairo, Systemic and cellular consequences of macrophage control of iron metabolism. Semin Immunol, 2012. 24(6): 393-8.
26. Weiss, G., Iron and immunity: A double-edged sword. Eur J Clin Invest, 2002. 32 Suppl 1: 70-8.
27. Ganz, T., Hepcidin and iron regulation, 10 years later. Blood, 2011. 117(17): 4425-33.
28. Armitage, A.E. et al., Hepcidin regulation by innate immune and infectious stimuli. Blood, 2011. 118(15): 4129-39.
29. Nemeth, E. and T. Ganz, The role of hepcidin in iron metabolism. Acta Haematol, 2009. 122(2-3): 78-86.
30. Nemeth, E. et al., Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science, 2004. 306(5704): 2090-3.
31. Peyssonnaux, C. et al., TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood, 2006. 107(9): 3727-32.
32. Theurl, I. et al., Autocrine formation of hepcidin induces iron retention in human monocytes. Blood, 2008. 111(4): 2392-9.
33. Cherayil, B.J., S. Ellenbogen, and N.N. Shanmugam, Iron and intestinal immunity. Curr Opin Gastroenterology, 2011. 27(6): 523-8.
34. Nairz, M. et al., The struggle for iron-A metal at the host-pathogen interface. Cell Microbiol, 2010. 12(12): 1691-702.
35. Scharte, M. and M.P. Fink, Red blood cell physiology in critical illness. Crit Care Med, 2003. 31(12 Suppl): S651-7.
36. Wessling-Resnick, M., Iron homeostasis and the inflammatory response. Annu Rev Nutr, 2010. 30: 105-22.
37. Correnti, C. and R.K. Strong, Mammalian siderophores, siderophore-binding lipocalins, and the labile iron pool. J Biol Chem, 2012. 287(17): 13524-31.
38. Srinivasan, G. et al., Lipocalin 2 deficiency dysregulates iron homeostasis and exacerbates endotoxin-induced sepsis. J Immunol, 2012. 189(4): 1911-9.
39. Canonne-Hergaux, F. et al., The Nramp1 protein and its role in resistance to infection and macrophage function. Proc Assoc Am Physicians, 1999. 111(4): 283-9.
40. Berger, T. et al., Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci U S A, 2006. 103(6): 1834-9.
41. Flo, T.H. et al., Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature, 2004. 432(7019): 917-21.
42. Raffatellu, M. et al., Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe, 2009. 5(5): 476-86.
43. Nairz, M. et al., Nitric oxide-mediated regulation of ferroportin-1 controls macrophage iron homeostasis and immune function in Salmonella infection. J Exp Med, 2013. 210(5): 855-73.
44. World Health Organization, Global prevalence of vitamin A deficiency in populations at risk 1995-2005. WHO Global Database on Vitamin A Deficiency, 2009. Geneva: World Health Organization.
45. Green, H.N. and E. Mellanby, Vitamin A as an anti-infective agent. Br Med J, 1928. 2(3537): 691-6.
46. Scrimshaw, N.S., C.E. Taylor, and J.E. Gordon, Interactions of nutrition and infection. World Health Organization Monograph Series, 1968. Geneva: World Health Organization, 329 pp.
47. Mayo-Wilson, E. et al., Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: Systematic review and meta-analysis. BMJ, 2011. 343: d5094.
48. Sudfeld, C.R., A.M. Navar, and N.A. Halsey, Effectiveness of measles vaccination and vitamin A treatment. Int J Epidemiol, 2010. 39 Suppl 1: i48-55.
49. Chambon, P., A decade of molecular biology of retinoic acid receptors FASEB J, 1996. 10(9): 940-54.
50. Semba, R.D., The role of vitamin A and related retinoids in immune function. Nutr Rev, 1998. 56(1 Pt 2): S38-48.
51. McDowell, E.M., K.P. Keenan, and M. Huang, Effects of vitamin A-deprivation on hamster tracheal epithelium. A quantitative morphologic study. Virchows Arch B Cell Pathol Incl Mol Pathol, 1984. 45(2): 197-219.
52. Rojanapo, W., A.J. Lamb, and J.A. Olson, The prevalence, metabolism and migration of goblet cells in rat intestine following the induction of rapid, synchronous vitamin A deficiency. J Nutr, 1980. 110(1): 178-88.
53. Brown, K.H., A. Gaffar, and S.M. Alamgir, Xerophthalmia, protein-calorie malnutrition, and infections in children. J Pediatr, 1979. 95(4): 651-6.
54. Villamor, E. and W.W. Fawzi, Effects of vitamin a supplementation on immune responses and correlation with clinical outcomes. Clin Microbiol Rev, 2005. 18(3): 446-64.
55. Kim, C.H., Retinoic acid, immunity, and inflammation. Vitam Horm, 2011. 86: 83-101.
56. Manicassamy, S. and B. Pulendran, Retinoic acid-dependent regulation of immune responses by dendritic cells and macrophages. Semin Immunol, 2009. 21(1): 22-7.
57. Twining, S.S. et al., Vitamin A deficiency alters rat neutrophil function. J Nutr, 1997. 127(4): 558-65.
58. Erickson, K.L., E.A. Medina, and N.E. Hubbard, Micronutrients and innate immunity. J Infect Dis, 2000. 182 Suppl 1: S5-10.
59. Hoglen, N.C. et al., Modulation of Kupffer cell and peripheral blood monocyte activity by in vivo treatment of rats with all-trans-retinol. Liver, 1997. 17(3): 157-65.
60. Ross, A.C., Vitamin A and retinoic acid in T cell-related immunity. Am J Clin Nutr, 2012. 96(5): 1166S-72S.
61. Cassani, B. et al., Vitamin A and immune regulation: Role of retinoic acid in gut-associated dendritic cell education, immune protection and tolerance. Mol Aspects Med, 2012. 33(1): 63-76.
62. Iwata, M., Retinoic acid production by intestinal dendritic cells and its role in T-cell trafficking. Semin Immunol, 2009. 21(1): 8-13.
63. Iwata, M. et al., Retinoic acid imprints gut-homing specificity on T cells. Immunity, 2004. 21(4): 527-38.
64. + T-cell subsets and effectively control intestinal inflammation. Gastroenterology, 2009. 137(4): 1391-402.e1-6.
65. Saurer, L., K.C. McCullough, and A. Summerfield, In vitro induction of mucosa-type dendritic cells by all-trans retinoic acid. J Immunol, 2007. 179(6): 3504-14.
66. Semba, R.D. et al., Abnormal T-cell subset proportions in vitamin-A-deficient children. Lancet, 1993. 341(8836): 5-8.
67. Stephensen, C.B., Vitamin A, infection, and immune function. Annu Rev Nutr, 2001. 21: 167-92.
68. Carman, J.A., S.M. Smith, and C.E. Hayes, Characterization of a helper T lymphocyte defect in vitamin A-deficient mice. J Immunol, 1989. 142(2): 388-93.
69. Mora, J.R. and U.H. von Andrian, Role of retinoic acid in the imprinting of gut-homing IgA-secreting cells. Semin Immunol, 2009. 21(1): 28-35.
70. Bahl, R. et al., Vitamin A administered with measles vaccine to nine-month-old infants does not reduce vaccine immunogenicity. J Nutr, 1999. 129(8): 1569-73.
71. Cherian, T. et al., Effect of vitamin A supplementation on the immune response to measles vaccination. Vaccine, 2003. 21(19-20): 2418-20.
72. Semba, R.D. et al., Effect of vitamin A supplementation on measles vaccination in nine-month-old infants. Public Health, 1997. 111(4): 245-7.
73. Benn, C.S. et al., Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa. Lancet, 1997. 350(9071): 101-5.
74. Newton, S. et al., Vitamin a supplementation does not affect infants’ immune responses to polio and tetanus vaccines. J Nutr, 2005. 135(11): 2669-73.
75. Benn, C.S. et al., Effect of vitamin A supplementation on measles-specific antibody levels in Guinea-Bissau. Lancet, 2002. 359(9314): 1313-4.
76. Benn, C.S., Combining vitamin A and vaccines: Convenience or conflict? Dan Med J, 2012. 59(1): B4378.
77. World Health Organization and Food and Agriculture Organization of the United Nations. Vitamin and Mineral Requirements in Human Nutrition, 2nd ed., 2004. Geneva, Rome: World Health Organization, FAO, xix, 341 pp.
78. Brown, K.H. et al., International Zinc Nutrition Consultative Group (IZiNCG) technical document #1. Assessment of the risk of zinc deficiency in populations and options for its control. Food Nutr Bull, 2004. 25(1 Suppl 2): S99-203.
79. Prasad, A.S., Effects of zinc deficiency on Th1 and Th2 cytokine shifts. J Infect Dis, 2000. 182(Suppl 1): S62-8.
80. Shankar, A.H. and A.S. Prasad, Zinc and immune function: The biological basis of altered resistance to infection. Am J Clin Nutr, 1998. 68(2 Suppl): 447S-63S.
81. Prasad, A.S., Zinc and immunity. Mol Cell Biochem, 1998. 188(1-2): 63-9.
82. Bhutta, Z.A. et al., Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: Pooled analysis of randomized controlled trials. Zinc Investigators’ Collaborative Group. J Pediatr, 1999. 135(6): 689-97.
83. Ruel, M.T. et al., Impact of zinc supplementation on morbidity from diarrhea and respiratory infections among rural Guatemalan children. Pediatrics, 1997. 99(6): 808-13.
84. Sazawal, S. et al., Zinc supplementation in young children with acute diarrhea in India. N Engl J Med, 1995. 333(13): 839-44.
85. Sazawal, S. et al., Zinc supplementation reduces the incidence of persistent diarrhea and dysentery among low socioeconomic children in India. J Nutr, 1996. 126(2): 443-50.
86. Sazawal, S. et al., Efficacy of zinc supplementation in reducing the incidence and prevalence of acute diarrhea-A community-based, double-blind, controlled trial. Am J Clin Nutr, 1997. 66(2): 413-8.
87. Sazawal, S. et al., Zinc supplementation reduces the incidence of acute lower respiratory infections in infants and preschool children: A double-blind, controlled trial. Pediatrics, 1998. 102(1 Pt 1): 1-5.
88. Bryce, J. et al., WHO estimates of the causes of death in children. Lancet, 2005. 365(9465): 1147-52.
89. Ballester, O.F. and A.S. Prasad, Anergy, zinc deficiency, and decreased nucleoside phosphorylase activity in patients with sickle cell anemia. Ann Intern Med, 1983. 98(2): 180-2.
90. Prasad, A.S., Zinc: Mechanisms of host defense. J Nutr, 2007. 137(5): 1345-9.
91. Beck, F.W. et al., Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans. Am J Physiol, 1997. 272(6 Pt 1): E1002-7.
92. Rabbani, P.I. et al., Dietary model for production of experimental zinc deficiency in man. Am J Clin Nutr, 1987. 45(6): 1514-25.
93. Prasad, A.S. et al., Serum thymulin in human zinc deficiency. J Clin Invest, 1988. 82(4): 1202-10.
94. Wieringa, F.T. et al., Reduced production of immunoregulatory cytokines in vitamin A- and zinc-deficient Indonesian infants. Eur J Clin Nutr, 2004. 58(11): 1498-504.
95. Bray, T.M. and W.J. Bettger, The physiological role of zinc as an antioxidant. Free Radic Biol Med, 1990. 8(3): 281-91.
96. Cousins, R.J., Absorption, transport, and hepatic metabolism of copper and zinc: Special reference to metallothionein and ceruloplasmin. Physiol Rev, 1985. 65(2): 238-309.
97. Prasad, A.S. et al., Antioxidant effect of zinc in humans. Free Radic Biol Med, 2004. 37(8): 1182-90.
98. Prasad, A.S. et al., Zinc enhances the expression of interleukin-2 and interleukin-2 receptors in HUT-78 cells by way of NF-kappaB activation. J Lab Clin Med, 2002. 140(4): 272-89.
99. Behrens, R.H., A.M. Tomkins, and S.K. Roy, Zinc supplementation during diarrhoea, a fortification against malnutrition? Lancet, 1990. 336(8712): 442-3.
100. Lira, P.I., A. Ashworth, and S.S. Morris, Effect of zinc supplementation on the morbidity, immune function, and growth of low-birth-weight, full-term infants in northeast Brazil. Am J Clin Nutr, 1998. 68(2 Suppl): 418S-24S.
101. Walker, C.L. and R.E. Black, Zinc for the treatment of diarrhoea: Effect on diarrhoea morbidity, mortality and incidence of future episodes. Int J Epidemiol, 2010. 39(Suppl 1): i63-9.
102. Bates, C.J. et al., A trial of zinc supplementation in young rural Gambian children Br J Nutr, 1993. 69(1): 243-55.
103. Shankar, A.H. et al., The influence of zinc supplementation on morbidity due to Plasmodium falciparum: A randomized trial in preschool children in Papua New Guinea. Am J Trop Med Hyg, 2000. 62(6): 663-9.
104. Muller, O. et al., Effect of zinc supplementation on malaria and other causes of morbidity in west African children: Randomised double blind placebo controlled trial. BMJ, 2001. 322(7302): 1567.
105. Veenemans, J. et al., Effect of supplementation with zinc and other micronutrients on malaria in Tanzanian children: A randomised trial. PLoS Med, 2011. 8(11): e1001125.
106. Haider, B.A. and Z.A. Bhutta, The effect of therapeutic zinc supplementation among young children with selected infections: A review of the evidence. Food Nutr Bull, 2009. 30(1 Suppl): S41-59.
107. Zeba, A.N. et al., Major reduction of malaria morbidity with combined vitamin A and zinc supplementation in young children in Burkina Faso: A randomized double blind trial. Nutr J, 2008. 7: 7.
108. Prasad, A.S. et al., Immunological effects of zinc deficiency in sickle cell anemia (SCA). Prog Clin Biol Res, 1989. 319: 629-47; discussion 648-9.
109. Prasad, A.S. et al., Effect of zinc supplementation on incidence of infections and hospital admissions in sickle cell disease (SCD). Am J Hematol, 1999. 61(3): 194-202.
110. Hewison, M., Vitamin D and immune function: An overview. Proc Nutr Soc, 2012. 71(1): 50-61.
111. Holick, M.F., Vitamin D deficiency. N Engl J Med, 2007. 357(3): 266-81.
112. Van Belle, T.L., C. Gysemans, and C. Mathieu, Vitamin D in autoimmune, infectious and allergic diseases: A vital player? Best Pract Res Clin Endocrinol Metab, 2011. 25(4): 617-32.
113. Gibson, R.S., Principles of Nutritional Assessment, 2nd ed. 2005. New York: Oxford University Press, xx, 908 pp.
114. Dawson-Hughes, B. et al., Estimates of optimal vitamin D status. Osteoporos Int, 2005. 16(7): 713-6.
115. Holick, M.F. and T.C. Chen, Vitamin D deficiency: A worldwide problem with health consequences. Am J Clin Nutr, 2008. 87(4): 1080S-6S.
116. Hewison, M., Vitamin D and the immune system: New perspectives on an old theme. Endocrinol Metab Clin North Am, 2010. 39(2): 365-79, table of contents.
117. Koeffler, H.P. et al., Gamma-interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages. Biochem Biophys Res Commun, 1985. 127(2): 596-603.
118. Tanaka, H. et al., 1 Alpha,25-dihydroxyvitamin D3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocyte-macrophages, but not into granulocytes. Biochem Biophys Res Commun, 1983. 117(1): 86-92.
119. Kreutz, M. et al., 1,25-Dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood, 1993. 82(4): 1300-7.
120. Liu, P.T. et al., Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science, 2006. 311(5768): 1770-3.
121. Gombart, A.F., N. Borregaard, and H.P. Koeffler, Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J, 2005. 19(9): 1067-77.
122. Adams, J.S. et al., Vitamin D-directed rheostatic regulation of monocyte antibacterial responses. J Immunol, 2009. 182(7): 4289-95.
123. Wang, T.T. et al., Cutting edge: 1,25-Dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol, 2004. 173(5): 2909-12.
124. Brennan, A. et al., Dendritic cells from human tissues expr ess receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol. Immunology, 1987. 61(4): 457-61.
125. Gregori, S. et al., Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol, 2001. 167(4): 1945-53.
126. Fabri, M. et al., Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Sci Transl Med, 2011. 3(104): 104ra102.
127. Lemire, J.M. et al., Immunosuppressive actions of 1,25-dihydroxyvitamin D3: Preferential inhibition of Th1 functions. J Nutr, 1995. 125(6 Suppl): 1704S-8S.
128. Chen, S. et al., Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol, 2007. 179(3): 1634-47.